Skip to Main Content

Paper Details

Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression.
Pituitary
12
2021
CD15, Functional, Functional tumors, Immune cell, LAG3, Lymphocyte, MSH2, MSH6, MutS protein homolog 2, MutS protein homolog 6, OX40, PD-L1, PD-L2, Pituitary tumors, T cells, V-domain Ig suppressor of T cell activation, VISTA, functional tumors, human, lymphocyte activation gene 3, macrophage, macrophages, mismatch repair proteins, pituitary tumor, pituitary tumor initiating cell, pituitary tumor initiating cells, pituitary tumors, primary brain tumors, primary tumors, programmed death ligand 1, programmed death ligand 2, recurrent tumors, tumor, tumor necrosis factor receptor superfamily member 4, tumors
Author NameAffiliation
Wenya Linda BiCenter for Skull Base and Pituitary Surgery, Harvard Medical School, Brigham and Women's Hospital
Wenya Linda BiDana-Farber Cancer Institute
Gavin P DunnWashington University School of Medicine
Gavin P DunnAndrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine
Malak AbedalthagafiKing Fahad Medical City and King Abdulaziz City for Science and Technology
Ian F DunnUniversity of Oklahoma Health Sciences Center
  • 1 - 6

Datasets

Release 1.2